The 2022 OncoAlert Colloquium Day 6: EONS Sessions

The 2022 OncoAlert Colloquium Day 5: GI Oncology

The 2022 OncoAlert Colloquium Day 4: ESGO Sessions and Gynaecological Oncology

The 2022 OncoAlert Colloquium Day 3: Lung Cancer

The 2022 OncoAlert Colloquium Day 2: GU Oncology

The 2022 OncoAlert Colloquium Day 1: Breast Cancer

Kinetics of postop circulating cell-free DNA and impact on MRD detection rates in resected stage I-III colorectal cancer

Breast-conserving therapy may be option for multiple breast lesions

ZUMA-7: Axi-cel is superior to standard of care across common prognostic subgroups in R/R LBCL

Shorter time from leukapheresis to infusion of axi-cel corresponds to better CR and OS in r/r LBCL patients

T-DXd demonstrates high levels of efficacy in patients with HER2+ unresectable and/or mBC previously treated with T-DM1

ASH 2022: Multiple myeloma roundup